Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12017 |
Methyllycaconitine citrate
MLA |
AChR | Neuroscience |
Methyllycaconitine citrate (MLA) 是一种可穿过血脑屏障的 α7 神经元烟碱乙酰胆碱受体(α7nAChR)拮抗剂,可用于研究神经系统疾病。 | |||
T70719 | MLAF50 | ||
MLAF50 is an inhibitor of the REV1 UBM2-Ubiquitin interaction. | |||
T27600 |
Imlatoclax
|
||
Imlatoclax has antineoplastic activity. | |||
T14967 |
Cimlanod
BMS-986231,CXL-1427 |
Others | Others |
Cimlanod is a second-generation Nitroxyl (HNO) donor for heart failure with positive lusitropic and inotropic as well as vasodilatory effects. Cimlanod delivers HNO via pH-dependent chemical breakdown when exposed to the neutral pH environment of the bloo | |||
T61715 | RmlA-IN-1 | ||
RmlA-IN-1 (Compound 8a) is a highly potent inhibitor of glucose-1-phosphate thymidylyltransferase (RmlA), with an IC50 value of 0.073 μM. It significantly modulates the biosynthesis of monosaccharide l-Rhamnose and impacts the permeability of the bacterial cell wall [1]. | |||
T39295 |
Remlarsen
MRG-201 |
||
Remlarsen (MRG-201), a miR-29b mimic, functions as a miR-29b agonist with the potential to prevent the formation of fibrotic scars or cutaneous fibrosis. | |||
T81656 |
Nomlabofusp
|
||
Nomlabofusp,作为一种TAT-cpp (1-12)类的细胞渗透性多肽,主要应用于Frataxin替代疗法的研究领域。 | |||
T76849 | Bamlanivimab | ||
Bamlanivimab (Anti-Human SARS-CoV-2) 是一种针对COVID-19的单克隆抗体(mAb),于2020年11月获得美国食品药品监督管理局(FDA)的紧急使用授权(EUA)。然而,由于SARS-CoV-2病毒耐药性变体的增多,该授权于2021年4月被撤销。 | |||
T70822 |
Gemlapodect
RO554965 |
||
Gemlapodect (RO554965),一种针对磷酸二酯酶 10A (PDE10A) 的抑制剂,主要应用于精神分裂症的研究。 | |||
T63779 |
RmlA-IN-2
|
||
RmlA-IN-2 是 1-磷酸葡萄糖胸苷转移酶 (RmlA) 的有效抑制剂 (IC50: 0.303 μM)。RmlA-IN-2 能够影响单糖 l-鼠李糖生物合成途径,并影响细菌细胞壁通透性。 | |||
T124286 |
Symlandine
|
||
Symlandine 是一种有用的有机化合物,可用于生命科学领域的相关研究,其产品编号为 T124286。 |